Literature DB >> 30606409

Iron Homeostasis in Healthy Kidney and its Role in Acute Kidney Injury.

Yogesh Scindia PhD1, Joseph Leeds Md1, Sundararaman Swaminathan Md2.   

Abstract

Iron is required for key aspects of cellular physiology including mitochondrial function and DNA synthesis and repair. However, free iron is an aberration because of its ability to donate electrons, reduce oxygen, and generate reactive oxygen species. Iron-mediated cell injury or ferroptosis is a central player in the pathogenesis of acute kidney injury. There are several homeostatic proteins and pathways that maintain critical balance in iron homeostasis to allow iron's biologic functions yet avoid ferroptosis. Hepcidin serves as the master regulator of iron homeostasis through its ability to regulate ferroportin-mediated iron export and intracellular H-ferritin levels. Hepcidin is a protective molecule in acute kidney injury. Drugs targeting hepcidin, H-ferritin, and ferroptosis pathways hold great promise to prevent or treat kidney injury. In this review we discuss iron homeostasis under physiological and pathologic conditions and highlight its importance in acute kidney injury.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Hepcidin; iron; ischemia-reperfusion; kidney; sepsis

Mesh:

Substances:

Year:  2019        PMID: 30606409     DOI: 10.1016/j.semnephrol.2018.10.006

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  22 in total

Review 1.  Ferritins in Kidney Disease.

Authors:  Kayla McCullough; Subhashini Bolisetty
Journal:  Semin Nephrol       Date:  2020-03       Impact factor: 5.299

2.  Kidney toxicity of the BRAF-kinase inhibitor vemurafenib is driven by off-target ferrochelatase inhibition.

Authors:  Yuntao Bai; Ji Young Kim; Bijay Bisunke; Laura A Jayne; Josie A Silvaroli; Michael S Balzer; Megha Gandhi; Kevin M Huang; Veronika Sander; Jason Prosek; Rachel E Cianciolo; Sharyn D Baker; Alex Sparreboom; Kenar D Jhaveri; Katalin Susztak; Amandeep Bajwa; Navjot Singh Pabla
Journal:  Kidney Int       Date:  2021-09-15       Impact factor: 18.998

3.  Artemether attenuates renal tubular injury by regulating iron metabolism in mice with streptozotocin-induced diabetes.

Authors:  Guangli Rong; Yuchun Cai; Wenci Weng; Yijun Chen; Xuewen Yu; Mumin Shao; Pengxun Han; Huili Sun
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

Review 4.  On Iron Metabolism and Its Regulation.

Authors:  Anne-Cathrine S Vogt; Tasneem Arsiwala; Mona Mohsen; Monique Vogel; Vania Manolova; Martin F Bachmann
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

Review 5.  The Iron Curtain: Macrophages at the Interface of Systemic and Microenvironmental Iron Metabolism and Immune Response in Cancer.

Authors:  Angela DeRosa; Avigdor Leftin
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

Review 6.  The pathological role of ferroptosis in ischemia/reperfusion-related injury.

Authors:  Hong-Fa Yan; Qing-Zhang Tuo; Qiao-Zhi Yin; Peng Lei
Journal:  Zool Res       Date:  2020-05-18

7.  Elevated serum iron level is a predictor of prognosis in ICU patients with acute kidney injury.

Authors:  Jie Shu; Yufeng Hu; Xueshu Yu; Jiaxiu Chen; Wenwei Xu; Jingye Pan
Journal:  BMC Nephrol       Date:  2020-07-25       Impact factor: 2.388

8.  Exposure to Iron Oxide Nanoparticles Coated with Phospholipid-Based Polymeric Micelles Induces Renal Transitory Biochemical and Histopathological Changes in Mice.

Authors:  Mihaela Balas; Ioana Mihaela Popescu Din; Anca Hermenean; Ludmila Otilia Cinteza; Anca Dinischiotu
Journal:  Materials (Basel)       Date:  2021-05-17       Impact factor: 3.623

9.  Hepcidin and Neutrophil Gelatinase-Associated Lipocalin as a Biomarker for Acute Kidney Injury Linked Iron Metabolism.

Authors:  Sun Young Cho; Mina Hur
Journal:  Ann Lab Med       Date:  2020-03       Impact factor: 3.464

Review 10.  Insight into Crosstalk between Ferroptosis and Necroptosis: Novel Therapeutics in Ischemic Stroke.

Authors:  Yue Zhou; Jun Liao; Zhigang Mei; Xun Liu; Jinwen Ge
Journal:  Oxid Med Cell Longev       Date:  2021-06-25       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.